---

     

Report Reveals Komen Gave Over $700 Thousand to Planned Parenthood in One Year

STOPP calls for end to Komen funding

By Michael Baggot

STAFFORD, VA, April 10, 2008 (LifeSiteNews.com) - In light of the continuing controversy over whether or not Catholics should support the Susan B. Komen for the Cure breast cancer organization, STOPP, a project of the American Life League dedicated to shutting down Planned Parenthood, released a report Wednesday detailing the $711,485 in funding various Komen affiliates contributed to PP branches across the nation from April 2005-April 2006. 

The STOPP report pinpoints 21 different Komen affiliates that have given significant sums of money to 26 different PP facilities.

The report also suggests that Komen's support for the abortion and contraceptive behemoth PP "does not make sense, since not only is there a direct connection between abortion and breast cancer, but scientific studies show that there is a direct connection between chemical contraception and breast cancer as well."

"The fact that Komen Affiliates give money to PP contradicts Komen's claim that it works to end breast cancer," adds the report.

STOPP is encouraging donors to end Komen support "until this organization repents and stops giving money to Planned Parenthood, an organization that kills babies, exploits women, corrupts youth and increases the likelihood of breast cancer by promoting contraception and abortion."

As LifeSiteNews.com reported in March, Komen has dismissed outright the scientifically supported connection between breast cancer and abortion (see http://www.lifesitenews.com/ldn/2008/mar/08033108.html).

Concerning the connection between breast cancer and the oral contraceptive pill, an important 1989 study "found that nulliparous women (i.e. women who have not had children) who took OCPs had a significantly higher rate of breast cell division than nulliparous women who did not take them. This was especially important because it is known that in general, cells that divide more rapidly are more vulnerable to carcinogens (i.e. cancer producing agents) and thus more likely to become cancerous," stated the Polycarp Research Institute.

Subsequent studies have confirmed the results of the 1989 research (see http://www.polycarp.org/overviewbreastcanceroralcontraceptiv...).

After discouraging Komen funding in February, the Little Rock Diocese in March issued an apology and retraction of their initial position. Following Little Rock's policy reversal, however, both the St. Louis and Lafayette dioceses reaffirmed their opposition to Komen support.

Both St. Louis and Lafayette encouraged readers to support local hospitals engaged in breast cancer research and treatment, rather than Komen.

See previous related LifeSiteNews.com coverage:

Two U.S. Dioceses Continue to Discourage Support for Komen Breast Cancer Foundation
http://www.lifesitenews.com/ldn/2008/mar/08033108.html

Catholic Diocese of Little Rock Flip Flops - Now Okays Funding Group which Supports Planned Parenthood
http://www.lifesitenews.com/ldn/2008/mar/08031103.html

Major U.S. Study Shows Oral Contraceptives Increase Breast Cancer Risk 44 %
http://www.lifesitenews.com/ldn/2006/oct/06102502.html

Read the STOPP report:
http://www.all.org/stopp/wsr080409.htm

Read the Coalition on Abortion/Breast Cancer's praise for Lafayette's statement (with important links on the abortion/breast cancer connection):
http://www.abortionbreastcancer.com/press_releases/080331 

Read alarming facts about Komen's connection to PP:
http://www.lifeissues.org/AbortionBreastcancer/komen/fact_sh...

Contact the Little Rock Respect Life Office by visiting its website:
http://www.dolr.org/offices/respectlife.php

Express your concerns to Komen:
Ms. Hala G. Moddelmog, president and CEO of Susan G. Komen for the Cure
5005 LBJ Freeway, Suite 250, Dallas, TX 75244-6125
877-465-6636 or 972-885-1600

 Back to Top

---

SHARE THIS STORY: E-mail  Print  Newsvine  Digg  Reddit  Del.icio.us  Facebook

---

---

MORE NEWS: LifeSiteNews.com Home Page  Last 10 Days   Archives   Special Reports

Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any Internet re-publishing of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. Republishing of articles on LifeSiteNews that have come from other news sources as noted is subject to the conditions of those sources.